Trial Outcomes & Findings for Beta Blockade in Critical Injury (NCT NCT00356187)

Results Overview

Recruitment status

TERMINATED

Study phase

PHASE2

Target enrollment

15 participants

Primary outcome timeframe

ICU admission date to ICU discharge or death

Results posted on

2018-03-15

Participant Flow

Insufficient enrollment to derive any results. Study closed in 2009 and is past data retention.

Participant milestones

Participant milestones
Measure	Propranol Treatment Propranolol	Standard of Care Results: 0 Insufficient enrollment to derive any results. Study closed in 2009 and is past data retention. PI has left institution and does not have any access to any data.
Overall Study STARTED	0	0
Overall Study COMPLETED	0	0
Overall Study NOT COMPLETED	0	0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Beta Blockade in Critical Injury

Baseline characteristics by cohort

Baseline data not reported

PRIMARY outcome

Timeframe: ICU admission date to ICU discharge or death

Population: Insufficient enrollment to derive any results. Study closed in 2009 and is past data retention. PI has left institution and does not have any access to any data.

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: ICU admission date to ICU discharge or death

Population: Insufficient enrollment to derive any results. Study closed in 2009 and is past data retention. PI has left institution and does not have any access to any data.

net nitrogen balance, fat-free mass, and fat mass

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: ICU admission date to ICU discharge or death

Population: Insufficient enrollment to derive any results. Study closed in 2009 and is past data retention. PI has left institution and does not have any access to any data.

blood glucose levels, insulin requirements, cortisol levels, IL-6 and IL-10 levels, infection rates, and organ dysfunction

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: ICU admission date to ICU discharge or death

Population: Insufficient enrollment to derive any results. Study closed in 2009 and is past data retention. PI has left institution and does not have any access to any data.

Ventilator days, ICU and hospital days, and in-hospital mortality

Outcome measures

Outcome data not reported

Adverse Events

Propranol Treatment

Serious events: 0 serious events

Other events: 0 other events

Deaths: 0 deaths

Standard of Care

Serious events: 0 serious events

Other events: 0 other events

Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Elizabeth Kingsley, Senior Grants Analyst

Denver Health and Hospital Authority

Phone: 3036027061

Email: [email protected]

Results disclosure agreements

Principal investigator is a sponsor employee
Publication restrictions are in place